Praxis Precision Medicines, Inc.
PRAX
$346.84
$3.641.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 28.26% | 37.70% | 57.10% | 131.13% | 125.34% |
| Gross Profit | -28.26% | -58.74% | -58.25% | -134.20% | -129.00% |
| SG&A Expenses | 100.21% | 29.13% | -17.66% | 23.39% | -9.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.66% | 35.88% | 37.14% | 101.00% | 76.59% |
| Operating Income | -41.66% | -51.74% | -37.87% | -102.91% | -78.41% |
| Income Before Tax | -33.57% | -51.52% | -42.43% | -117.67% | -75.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.57% | -51.52% | -42.43% | -117.67% | -75.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.57% | -51.52% | -42.43% | -117.67% | -75.20% |
| EBIT | -41.66% | -51.74% | -37.87% | -102.91% | -78.41% |
| EBITDA | -41.70% | -51.80% | -38.06% | -103.37% | -78.77% |
| EPS Basic | 2.63% | -19.16% | -22.38% | -90.80% | -15.70% |
| Normalized Basic EPS | 3.64% | -14.21% | -22.39% | -90.81% | -17.49% |
| EPS Diluted | 2.63% | -19.16% | -22.38% | -90.80% | -15.70% |
| Normalized Diluted EPS | 3.64% | -14.21% | -22.39% | -90.81% | -17.49% |
| Average Basic Shares Outstanding | 37.18% | 27.16% | 16.38% | 14.08% | 51.43% |
| Average Diluted Shares Outstanding | 37.18% | 27.16% | 16.38% | 14.08% | 51.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |